65
Views
35
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease

, , , , &
Pages 282-288 | Received 14 Mar 2006, Accepted 05 Jun 2006, Published online: 02 Jan 2014

References

  • Kitada K, Oka S, Kimura S, Shimada K, Serikawa T, Yamada J, et al. Detection of Pneumocystis carinii sequences by polymerase chain reaction: animal models and clinical application to noninvasive specimens. J Clin Microbiol 1991;29:1985–90.
  • Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K, et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evalua-tion of clinical features of P. Carinii pneumonia in rheumatic dis-eases. Ftheumatology 2004;43:479–85.
  • Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5–13.
  • Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J. Pneumocystis carinii pneumonia: a comparison be-tween patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663–71.
  • Peters SG, Prakash UBS. Pneumocystis carinii pneumonia: review of 53 cases. Am J Med 1987;82:73–8.
  • Sepkowitz KA. Pneumocystis carinii pneumonia in patients with-out AIDS. Clin Infect Dis 1993:17 (suppl):5416–22.
  • Mansharamani NG, Garland R, Delaney D, Koziel H. Manage-ment and outcome patterns for adult Pneumocystis carinii pneu-monia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000;118:704–11.
  • Limper AH, Offord KP, Smith TF, Martin WJ. Pneumocystis carinii pneumonia differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204–9.
  • Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998;113:1215–24.
  • Godeau B, Coutant-Perronne V, Huoung DLT, Guille yin L, Magadura G, De Bandt M, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Ftheumatol 1994;21: 246–51.
  • Thomas CF, Limper AH. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin Respir Infect 1998;13:289–95.
  • Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992;267:832–7.
  • Gerard J. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995;162:233–5.
  • Huynh-Do U, Gantenbein H, Binswanger U. Pneumocystis carinii pneumonia during immunosuppressive therapy for anti-neutrophil cytoplasmic auto antibody-positive vasculitis. Arch Intern Med 1995;155:872–4.
  • Arend SM, Kroon FP, Van't Wout JW. Pneumocystis carinii Pneumonia in patients without AIDS, 1980 through 1993. Arch Intern Med 1995;155: 2436–41.
  • Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengraju M, Ohtsuka K, et al. Decreased production of interleukin-12 and other Th-1 cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998;41:838–44.
  • Houtman PM, Stenger AA, Bruyn GA, Mulder J. Methotrexate may affect certain T lymphocyte subsets in rheumatoid arthritis resulting in susceptibility to Pneumocystis carinii infection. J Ftheumatol 1994;21:1168–70.
  • Kane GC, Troshinisky MB, Peters SP, Israel HL. Pneumocystis carinii pneumonia associated with weekly methotrexate: cumula-tive dose of methotrexate and low CD4 cell count may predict this complication. Respir Med 1992;87:153–5.
  • Kane GC, Israle HL, Peters SP. Pneumocystis carinii pneumonia and methotrexate therapy. Chest 1993;103:1923.
  • Le Moal G, Breux JP, Roblot F. Discontinuing prophylaxis against Pneumocystis carinii pneumonia. N Engl J Med 2001;344:1639–41.
  • Porges AJ, Beattie SL, Ftitchlin C, Kimberly RP, Christian CL. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Ftheumatol 1992;19:1191–4.
  • Tai TL, O'Rourke KP, McWeeney M, Burke CM, Sheehan K, Barry M. Pneumocystis carinii pneumonia following a second in-fusing of infliximab. Ftheumatology 2002;41:951–2.
  • Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor-neutralizing agent. N Engl J Med 2001;345: s1098–104.
  • Kolls JK, Lei D, Vasquez C, Odom G, Summer WR, Nelson S, et al. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am J Respir Cell Mol Biol 1997;16:112–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.